 |
Previous Article | Next Article 
The Journal of Neuroscience, February 1, 2001, 21(3):849-857
ATP-Binding Cassette Transporter ABC2/ABCA2 in the Rat Brain: A
Novel Mammalian Lysosome-Associated Membrane Protein and a Specific
Marker for Oligodendrocytes But Not for Myelin Sheaths
Cheng-Ji
Zhou1, 4,
Li-Xia
Zhao2,
Nobuya
Inagaki2, 5,
Jian-Lian
Guan1,
Shigeo
Nakajo3,
Takahiro
Hirabayashi3,
Sakae
Kikuyama4, and
Seiji
Shioda1, 5
1 Department of Anatomy, Showa University School of
Medicine, Tokyo, 142-8555 Japan, 2 Department of
Physiology, Akita University School of Medicine, Akita, 010-8543 Japan,
3 Laboratory of Biological Chemistry, Showa University
School of Pharmaceutical Sciences, Tokyo, 142-8555 Japan,
4 Department of Biology, Waseda University School of
Education, Tokyo, 168-8050 Japan, and 5 Department of
Anatomy I, Showa University School of Medicine, Core Research for
Evolutional Science and Technology, Japan Science and Technology
Corporation, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555 Japan
 |
ABSTRACT |
We recently cloned a full-length cDNA of the rat ATP-binding
cassette transporter 2 (ABC2, or ABCA2) protein, a member of the ABC1
(or ABCA) subfamily (-ABC1/ABCA1 is a causal gene for Tangier
disease) and found it to be strongly expressed in the rat brain. In
this study, we identified ABC2 as a lysosome-associated membrane
protein that is being localized specifically in oligodendrocytes. The
ABC2-immunolabeled cells were detected mainly in the white matter but
were also scattered in gray matter throughout the whole brain. In
addition, these cells were found to be colocalized with 2',3'-cyclic
nucleotide-3'-phosphodiesterase (CNPase) immunoreactivity when the
marker antibody for oligodendrocytes was used. However, no such
colocalization was observed with markers for other kinds of glial
cells. Unlike the CNP antibody, which also intensely stains myelin
sheaths in the white matter, ABC2 immunoreactivity was detected only in
the cell bodies of oligodendrocytes. At the ultrastructural level, ABC2
immunoreactivity was detected mostly around lysosome and partly in
Golgi apparatus by electron microscopy. This was confirmed by
immunocolocalization of ABC2 and lysosomal markers in a neuroblastoma
cell line. Immunoblotting analysis of ABC2 from the whole brain and the
ABC2-transfected cell line revealed bands at ~260 kDa. The result of
in situ hybridization with a riboprobe for ABC2 matched
the results obtained from immunostaining. These findings strongly
suggest that ABC2 is a specific marker for oligodendrocytes but not for
myelinsheaths and that it is as a novel mammalian lysosome-associated
membrane protein involved in myelinization or other kinds of metabolism
in the CNS.
Key words:
ATP-binding cassette (ABC) transporter; ABC1 (or ABCA)
subfamily; ABC2/ABCA2; oligodendrocytes; myelinization; lysosomes; marker protein; CNPase; lysosome-associated membrane protein
LAMP1/LAMP2; rat brain
 |
INTRODUCTION |
To date, hundreds of evolutionarily
conserved membrane proteins have been identified as members of the
ATP-binding cassette (ABC) transporter (or traffic ATPase) superfamily.
These proteins have been implicated in the energy-dependent transport
of a wide variety of substrates across the organellar or plasma
membranes of both prokaryotic and eukaryotic cells (Higgins, 1992 ;
Doige and Ames, 1993 ; Allikmets et al., 1996 ; Linton and Higgins, 1998 ; Saurin et al., 1999 ). Typical eukaryotic ABC transporters
(full-molecule) consist of two transmembrane domains and two
ATP-binding cassettes. Half-molecule transporters have only a single
transmembrane domain and ATP-binding cassette, whereas quarter-molecule
transporters have only an ATP-binding cassette (Hyde et al., 1990 ; Dean
and Allikmets, 1995 ; Decottignies and Goffeau, 1997 ).
Many mammalian ABC transporters have recently been found to be
associated with clinically relevant phenotypes, including
neurodegenerations. X-linked adrenoleukodystrophy (ALD), which results
in a fatal demyelinating disease, has been linked to mutations in a 70 kDa peroxisomal ABC transporter (Kamijo et al., 1990 ; Mosser et al., 1993 ; Dubois-Dalcq et al., 1999 ), and an autosomal recessive retinal disorder, Stargardt's macular dystrophy, has been connected to a
retina-specific ABC transporter (ABCR/ABCA4) gene (Allikmets et al.,
1997 ; Illing et al., 1997 ; Weng et al., 1999 ). Other genetic diseases
reported to be linked to mutations of ABC transporters include cystic
fibrosis (Sheppard and Welsh, 1999 ), persistent hyperinsulinemic
hypoglycemia of infancy (Thomas et al., 1995 ), congenital jaundice
(Paulusma et al., 1996 ), intrahepatic cholestasis (Strautnieks et al.,
1998 ), and pseudoxanthoma elasticum (Ringpfeil et al., 2000 ).
We have cloned and characterized a full-length rat ATP-binding cassette
transporter cDNA for ABC2/ABCA2, which encodes for a glycoprotein of
2434 amino acids with 44.5, 40.0, and 40.8% identity with mouse
ABC1/ABCA1, human ABC3/ABCA3, and human ABCR/ABCA4, respectively (Zhao
et al., 2000 ). ABC2 belongs to the ABC1 (ABCA) subfamily, which is
structurally distinct from other subfamilies. Four members of this
subfamily have been identified and named ABC1 (Luciani et al., 1994 ),
ABC2 (Luciani et al., 1994 ; Zhao et al., 2000 ), ABC3 (ABC-C) (Klugbauer
and Hofmann, 1996 ), and ABCR (Illing et al., 1997 ). This subfamily has
recently received much attention because it has been proposed
that ABC1 and ABCR are flippases (Higgins, 1994 ; Weng et al.,
1999 ), and they have also been identified as the causal genes for
Tangier disease (Bodzioch et al., 1999 ; Brooks-Wilson et al., 1999 ;
Rust et al., 1999 ; Orso et al., 2000 ) and Stargardt's macular dystrophy.
Although it has been reported that ABC2 is expressed abundantly in rat
and mouse brains (Luciani et al., 1994 ; Zhao et al., 2000 ) and it has
been hypothesized that ABC2 may play a very important role in the
mammalian CNS, knowledge of the morphology and physiological functions
of this protein remains poor. The present study aims to identify the
ABC2-expressing cell types in the brain and to determine its
ultrastructural localization.
 |
MATERIALS AND METHODS |
Animals
Two or four male adult rats (2- or 3-month-old Sprague Dawley;
Saitama Experimental Animal Center, Saitama, Japan) were used for each
experiment. Rats were housed in a temperature- and light-controlled room (22°C, lights on at 6:00 A.M. and off at 8:00 P.M.) and
fed standard Oriental Chow and water ad libitum. Two to five
animals were used in each experiment. During the experiments, all
efforts were made to minimize suffering of the animals, in accordance with the National Institutes of Health Guidelines for the Care and Use of Laboratory Animals.
Primary antibodies
The specific antibody for ABC2 was raised in rabbits against the
synthetic peptide corresponding to 20 C-terminal amino acid residues
(GLISFEEERAQLSFNTDTLC) of rat ABC2, which constructively differs from
the other members of the ABC1 subfamily or any other protein
from the sequence databases. The antibody was purified using
affinity chromatography (HiTrap Protein G, Amersham Pharmacia Biotech).
To identify the ABC2-expressing cell types in this study, double
immunofluorescence was performed using the monoclonal mouse anti-human
2',3'-cyclic nucleotide-3'-phosphodiesterase (CNPase; Sigma C5922) as a
marker for oligodendrocytes (Sprinkle et al., 1987 ) and the monoclonal
mouse anti-rat CD11b (Serotec, Kidlington, Oxford, England) as a marker
for microglial cells in the brain (Milligan et al., 1991 ). In addition,
the rabbit anti-myelin basic protein (MBP) (Dako, Carpinteria, CA) and
the rabbit anti-glial fibrillary acidic protein (GFAP; Sigma G9269), a
marker for astrocytes, were also used. Furthermore, two
affinity-purified goat polyclonal antibodies against human
lysosome-associated membrane proteins LAMP1 (N-19; Santa Cruz
Biotechnology, Santa Cruz, CA) and LAMP2 (C-20; Santa Cruz
Biotechnology) were used to identify the lysosomal colocalization (Karlsson and Carlsson, 1998 ).
Western blot analysis
Cell culture and transfection. To demonstrate the
specificity of the antibody for ABC2 used in the present study, the rat ABC2 expression vector (pCMVrABC2) was transfected into cultured COS-1
cells. Culture and transfection of COS-1 cells was performed as
previously described (Zhao et al., 2000 ). Briefly, cells were plated on
35 mm culture dishes at a density of 2 × 105 cells per dish 24 hr before
transfection and cultured in DMEM (450 mg/dl glucose) supplemented with
10% fetal calf serum. Two micrograms of pCMVrABC2 were transfected
into cells with Lipofectamine and Opti-MEM I (Life Technologies),
according to the manufacturer's instructions.
Crude membrane preparation. Crude membrane from COS-1 cells
was prepared as described previously (Zhao et al., 2000 ). Briefly, for
immunoblot analysis, 3 d after transfection with pCMVrABC2 or pCMV
vector alone, the COS-1 cells were washed three times with PBS,
suspended in buffer A consisting of 50 mM Tris,
pH 7.5, and 1 mM EDTA containing protease
inhibitor mixture (10 µl/ml) (Sigma), homogenized, and then
centrifuged at 100,000 × g for 1 hr at 4°C. The
pellets were resuspended in 500 µl of buffer A and stored at 80°C
until used. Protein concentrations were determined using the BCA assay
(Pierce, Rockford, IL). For preparation of crude membrane from the rat
brain, the whole brain were immediately dissected into buffer A
containing protease inhibitor mixture (10 µl/ml) (Sigma), and the
tissue suspension was homogenized in a Teflon pestle-glass homogenizer
on ice and centrifuged at 800 × g for 7 min at 4°C.
The supernatant was subjected to ultracentrifugation at 100,000 × g for 1 hr at 4°C, and the collected pellets were resuspended in 500 µl of buffer A and stored at 80°C until
immunoblot analysis.
Immunoblot analysis. The crude membrane proteins from brain
tissue (60 µg) or from the COS-1 cells (3 µg) were boiled in SDS reducing sample buffer for 10 min and electrophoresed on a 7% SDS-polyacrylamide gel, then transferred electrophoretically to a
nitrocellulose membrane (Hybond ECL, Amersham Pharmacia Biotech) at
4°C at 200 mA overnight. The membrane was blocked in 5% defatted milk in 0.1% Tween 20-PBS (PBS-T) for 1 hr at room temperature. After
washing with PBS-T, the membrane was incubated with 1:500 diluted ABC2
antibody for 2 hr at room temperature and washed with PBS-T. The
membrane was then incubated with 1:5000 diluted horseradish
peroxidase-conjugated anti-rabbit IgG (Amersham Pharmacia Biotech) for
1 hr at room temperature. After washing with 0.3% Tween 20-PBS and
then with PBS-T, protein bands were detected using an enhanced
chemiluminescence system (ECL, Amersham Pharmacia Biotech),
according to the manufacturer's instructions.
Immunohistochemistry
Tissue preparation. The animals were deeply
anesthetized with pentobarbital (50 mg/kg, i.p.) and perfusion-fixed
with 4% paraformaldehyde and 0.1% glutaraldehyde buffer, pH 7.4. Then
the brains were removed quickly and post-fixed in 4% paraformaldehyde
for 2 hr or more. After the brains were permeated with 20% sucrose for
1 or 2 d, they were frozen in an embedding compound (Sakura
Finetechnical, Tokyo, Japan) on isopentane using liquid nitrogen and
stored at 70°C until used. Frozen 7-µm-thick coronal or sagittal
sections were cut with a cryostat (Microm HM500, Heidelberg, Germany)
and thaw-mounted on poly-L-lysine-coated glass slides.
Immunofluorescence. This procedure was performed as
described previously (Zhou et al., 1999 ), although with some
modification in relation to double labeling. The brain sections were
blocked in 10% normal goat serum (NGS) and 1% bovine serum albumin,
as well as 0.3% Triton X-100, in 0.1 M PBS for 1 hr at room temperature. Except for the MBP antibody that was used
directly, each primary antiserum was diluted 1:500 in PBS containing
1% NGS or diluted together for double staining and was incubated
overnight at 4°C. The antisera were then rinsed and incubated with
one or two secondary antibodies for 1 hr at room temperature. For
ABC2/CNP double labeling, Alexa 546-conjugated goat anti-rabbit IgG
(for ABC2) and Alexa 488-conjugated goat anti-mouse IgG (for CNPase)
were diluted 1:200 in PBS. In the case of ABC2/CD11b double labeling,
Alexa 488-conjugated goat anti-rabbit IgG (for ABC2) and Alexa
546-conjugated goat anti-mouse IgG (for CNPase) were used. For MBP or
GFAP single staining, Alexa 546-conjugated goat anti-rabbit IgG was
used as the second antibody. After washing in PBS, the sections were
counterstained with Hoechst 33258 (1 µg/ml, Sigma) for 1 min and
rinsed. In the case of ABC2/LAMP1 double staining, Alexa 546-conjugated
donkey anti-goat IgG (for LAMP1) was used first, and then Alexa
488-conjugated goat anti-rabbit IgG (for ABC2) was used. For
ABC2/LAMP2, Alexa 488-conjugated donkey anti-goat IgG (for LAMP2) was
used first, and then Alexa 546-conjugated goat anti-rabbit IgG (for
ABC2) was used. The slides were then coverslipped with PermaFluor
Aqueous mounting medium (Immunon, Pittsburgh, PA).
Fluoromicroscopy and confocal microscopy. Fluorescence
immunolabeling was detected using a U-MNIBA filter cube (Olympus,
Tokyo, Japan) for Alexa 488, a U-MWIG filter cube for Alexa 546, and a
U-MNU filter cube for Hoechst 33258. A U-MDA/FI/TR cube was used for
triple-fluorescence immunolabeling with a fluoromicroscope (AX-70,
Olympus). In the case of ABC2/LAMP1 or LAMP2 double staining, the
confocal microscope (Leica TCS SP2, Leica, Microsystems, Heidelberg, Germany) was used.
Immunoelectron microscopy
Free-floating immunolabeling. Vibratome sections
(30 µm) from the perfusion-fixed brain tissue were used to perform a
preembedding immunoperoxidase method. After blocking and permeation as
described above, the sections were floated in the primary antibody
buffer (rabbit anti-ABC2, 1:1000) on ice overnight. A biotinylated
anti-rabbit IgG (Vector Labs, Burlingame, CA) (diluted 1:400) was used
as the secondary antibody, with a 1 hr incubation at room temperature. The sections were then labeled with avidin biotin-peroxidase complex (ABC Kit, Vector) and color-developed with a 3,3'-diaminobenzidine tetrahydrochloride (DAB)-substrate kit (Vector) for light-microscope or
direct electron microscope observation.
Silver-gold intensification. To obtain clearer electron
micrographs (or for double staining to detect a secondary antigen), the
peroxidase-DAB reaction product was intensified as described previously (Guan et al., 2000 ). Briefly, the sections (after DAB reaction) were treated with 10% thioglycolic acid for 2 hr at room
temperature to inhibit nonspecific binding of silver in tissue compartments and rinsed with 2% sodium acetate. Then the sections were
transferred to a physical developer (Gallyas et al., 1982 ) (mixture of 0.2 ml 37% formalin, 50 ml solution containing 0.2% ammonium nitrate, 0.2% silver nitrate, 1% silicotungstic
acid, and 50 ml 5% sodium carbonate) for 3-10 min for silver
intensification, after which the reaction was stopped with 1% acetic
acid, and the sections were rinsed with 2% sodium acetate. Finally,
the sections were transferred into a 0.05% gold chloride solution for
10 min to enhance the stability of the metallic particles and the
electron density, then rinsed and recovered in 0.1 M PBS, pH 7.4, for use in the next step.
Electron microscopy. The sections were post-fixed with
1% osmium tetroxide (in 0.1 M PBS), dehydrated with a
graded series of ethanol, and flat-embedded in Epon-Araldite mixture.
Ultrathin sections were cut with a Reichert Ultracut Microtome, from
the corpus callosum, anterior commissure, optic chiasm, and the medulla of cerebellum, and observed using a Hitachi H7000 electron microscope without counterstaining. The morphological identification for oligodendrocytes and other glial cells as well as the organellar structures were consulted in Peters et al. (1976) .
In situ hybridization. The first half of this
experiment was performed as described previously (Zhao et al., 2000 ).
The fresh-frozen brain sections and a
[35S]-labeled 400 bp ABC2 riboprobe were used.
Slide emulsion and signal development. As a continuous
procedure (Shioda et al., 1997 ), the slides of hybridized brain
sections (after exposure to x-ray film) were dipped in a nuclear track emulsion (NTB2; Kodak, Rochester, NY) at 42°C, air-dried, and then
left in the dark to expose for 1 week. They were then developed in a
Kodak D19 developer (20°C, 2 min), fixed in Kodak Rapid Fixer, counterstained with hematoxylin and eosin, and then analyzed under dark- and bright-field microscopy.
 |
RESULTS |
Immunoblot analysis of rat brain and ABC2-transfected cells
Immunoblot analysis for both brain tissue and the transfected cell
samples was performed using the specific antibody for ABC2. A single
band between molecular weight 260 and 250 kDa was detected from the
total membrane fraction of the rat whole brain (Fig. 1, lane 1), and two bands of
260 and 250 kDa were detected from the total membrane fraction of COS-1
cells transfected with ABC2 expression vector (pCMVrABC2) (Fig. 1,
lane 2). However, no band was detected from those
transfected with pCMV vector only (Fig. 1, lane 3).

View larger version (41K):
[in this window]
[in a new window]
|
Figure 1.
Immunoblot analysis of ABC2 protein. Membrane
proteins from rat whole brain (60 µg) (lane 1) and
COS-1 cells transfected with ABC2 expression vector (3 µg)
(pCMVrABC2) (lane 2) and pCMV vector alone (3 µg)
(lane 3) were electrophoresed on a 7%
SDS-polyacrylamide gel. For immunoblot analysis, 1:500 diluted
anti-ABC2 rabbit antibody and 1:5000 diluted horseradish
peroxidase-conjugated anti-rabbit IgG were used as the primary and
secondary antibodies, respectively. Proteins were detected using an
enhanced chemiluminescence system. Molecular weights of markers are
indicated on the left, and the detected 260 and 250 kDa
bands are indicated by arrows.
|
|
Cellular identification of ABC2 in the cerebellum and the
anterior commissure
In the cerebellum of rats considered in this study, intense ABC2
immunoreactivity was clearly observed in those cell bodies that were
mainly distributed in the medulla and scattered in the granular layer
(Fig.
2A,B,D,E,
red labeling for ABC2). In the medulla, the
ABC2-immunolabeled cells showed oval-shaped and rare dendrite
morphological characteristics (Fig. 2E,
red labeling, G, green labeling for
ABC2) and can therefore be considered to be oligodendrocytes. Further
evidence to this effect was obtained in two subsequent
double-immunofluorescence staining experiments (Fig.
2A-I). All ABC2-immunolabeled cell bodies in
both the medulla and the granular cell layer (Fig.
2B,E, red labeling for
ABC2) were found to be co-immunostained in the same tissue sections with an antibody against CNP, a marker protein that exists
both in oligodendrocytes and in the myelin sheath (Fig.
2C,F, green labeling for CNP).

View larger version (84K):
[in this window]
[in a new window]
|
Figure 2.
Identification of the
ABC2-immunolabeled cell type in the brain section. A-F,
ABC2 immunoreactivity is restricted to cell bodies that have been
identified by CNP marker as being oligodendrocytes.
A-C, Low-magnification micrographs indicate that the
immunoreactivities of both ABC2 (red) and CNP
(green) are localized mainly in the medulla and
apparently rarely in the granular cell layer. D-F,
Zoom-in micrographs from A to C,
respectively, show the precise colocalization of ABC2-immunolabeled
cells with CNP; the arrows indicate the same location of
the immunolabeled cells under different fluorescence microscopes.
A, D, The red fluorescence
(Alexa 546) represents ABC2 immunoreactivity and the
blue (Hoechst 33258) indicates all nuclei, including a
large number of nonimmunolabeled cells. B,
E, Only ABC2 immunoreactivity is visible in the positive
cell bodies. C, F, The
green fluorescence labeling (Alexa 488) that represents
the marker protein of CNP exists in both the oligodendrocytes and the
myelin sheath. It is of note that all red ABC2 labeling
surrounding the nuclei overlapped with green CNP
labeling. MoCb, Molecular layer; GL,
granular layer; M, medulla of the cerebellum.
G-I, ABC2-immunoreactivity does not colocalize with
marker labeling of CD11b for microglial cells. G, For
comparison with I, ABC2 is labeled using
green fluorescence (Alexa 488) is labeled for ABC2, and
the oval-shaped positive cells (arrows) are observed.
H, All cell nuclei are stained blue by
Hoechst 33258; the arrows (the same as those used in
G) showing the nuclei locations of ABC2-immunolabeled
cells in the medulla of the cerebellum and the
arrowheads showing the nuclei of
CD11b-immunolabeled cells (in I) indicate
that there was no overlap with these two kinds of immunolabeling.
I, The microglial cell bodies, which are immunolabeled
with a marker antibody against CD11b (Alexa 546, red), are morphologically distinct from
ABC2-immunolabeled cells (G) in the same tissue
sections of the cerebellum. J-L, ABC2-immunoreactivity
in the anterior commissure (ac) compared with MBP and
GFAP immunoreactivities. All positive immunoreactivities by above
antibodies in the neighboring brain sections are labeled using
red fluorescence (Alexa 546) and counterstained with
Hoechst 33258. J, Most of the ABC2-immunolabeled cell
bodies are distributed in the white matter region. K,
The MBP immunoreactivity is observed intensely in the white matter,
especially in the myelin sheaths and the oligodendrocytes, but the cell
bodies are difficult to distinguish. L, The distribution
of the GFAP immunolabeling, which specifically for astrocytes clearly
shows a different localization pattern from oligodendrocytes
immunolabeled by ABC2 or MBP antibodies. Scale bars, 50 µm.
|
|
To confirm that ABC2 immunoreactivity was not localized in other kinds
of glial cells, we chose an antibody against CD11b, a marker for
microglial cells in brain sections, for double immunostaining with
ABC2. This time, ABC2 immunoreactivity was labeled with green fluorescence and found to be restricted to oval-shaped cell bodies (Fig. 2G). The red-labeled CD11b immunoreactivity, on the
other hand, was localized in another kind of cell, identified as the microglia cell type (Fig. 2I), and there was no
observable overlap between the nuclei of these two immunolabeled cell
types (Fig. 2H).
Further confirming staining was showed in the anterior commissure (Fig.
2J-L). The intense ABC2-immunoreactived cell bodies were clearly observed in the white matter region (Fig.
2J, red labeling), and this region from a
neighboring section stained with MBP antibody showed intense positive
labeling for myelin basic protein in whole white matter (Fig.
2K, red labeling). However, with an
antibody for GFAP, the marker for astrocytes, most positive labeling
was observed in the gray matter at the anterior commissure, and rare
positive immunoreactivity was detected in the white matter (Fig.
2L, red labeling).
Distribution of ABC2 in various brain regions
In addition to its distribution in the cerebellum as well as the
anterior commissure, the distribution of ABC2 immunoreactivity in both
the gray and white matter of other brain regions was also investigated
in this study by double-immunofluorescence labeling with CNP (Fig.
3). In the gray matter of the olfactory
bulb (Fig. 3A, OB), cerebral cortex (Fig.
3B,J, CX),
dentate gyrus (Fig. 3C, DG), corpora quadrigemina
(Fig. 3L, CQ), thalamus, and hypothalamus, as
well as in other parts, the double-immunolabeled (for ABC2 and CNP;
overlapped as the yellow labeling) cells were found to be
scattered within neurons and other kinds of glial cells.

View larger version (94K):
[in this window]
[in a new window]
|
Figure 3.
Distribution of ABC2 immunoreactivity,
co-immunolabeled with CNP, in the gray matter and white matter from
different brain sections. The yellow positive labeling
(some cells are indicated by arrowheads), which
indicates colocalization of double fluorescence of Alexa 546 (red, for ABC2) and Alexa 488 (green, for CNP) in the same cells, was observed
through a triple fluorescence filter cube. All cell nuclei in each
brain section were labeled blue by Hoechst 33258. It is
clear that the double-immunolabeled cells are rarely found in the gray
matter (A-C) but occur much more
frequently in the olfactory tubercle (G) and
corpora quadrigemina (L) and are distributed
mainly in the white matter (D-F,
H-K). 3V, Third
ventricle; ac, anterior commissure; CA1,
CA3, the CA1 or CA3 field of the hippocampus;
cc, corpus callosum; cg, cingulum;
CQ, corpora quadrigemina; CX, cerebral
cortex; DG, dentate gyrus of the hippocampal formation;
dhc, dorsal hippocampal commissure;
fmi, forceps minor corpus callosum;
LV, lateral ventricle; OB, olfactory
bulb; ox, optic chiasm; sm, stria
medullaris thalamus; Tu, olfactory tubercle;
vhc, ventral hippocampal commissure. Scale bars, 50 µm.
|
|
In white matter throughout the entire brain, ABC2-immunostained cells
were found to be in the majority. Intense double-immunolabeled cells
were observed especially in the corpus callosum (Fig.
3D,E,J, cc),
from the forceps minor part (Fig. 3D, fmi) to the
forceps major part, the cingulum (Fig. 3J, cg),
the ventral (Fig. 3E, vhc) and dorsal (Fig.
3F, dhc) hippocampal commissure, the anterior commissure (Fig. 3H, ac), the stria medullarias
thalamus (Fig. 3K, sm), the optic chiasm (Fig.
3I, ox), the olfactory tubercle (Fig.
3G, Tu), the olfactory tract, and the fibers
pons, as well as in other regions.
Ultrastructural localization of ABC2 in oligodendrocytes
The white matter of brain tissues was cut ultrathin for the
purposes of electron microscopy. In the medulla of the cerebellum, most
of silver-gold particles that intensified the peroxidase-DAB reaction
product for ABC2 immunoreactivity were found to be mostly distributed
around the lysosomes of the oligodendrocytes (Fig. 4A). Using high
magnification, the dense silver-gold particles, which were
morphologically characterized as lysosomes (Fig. 4B), were clearly observed in the organellar membrane. The dense
particles were also observed particularly in the trans face
of the Golgi apparatus, and no specific particles were observed in all
mitochondria and most endoplasmic reticulum or nucleus (Fig.
4B). At least 20 oligodendrocytes in cerebellum or
other brain regions were examined. No specific ABC2 immunoreactivity
was detected in the myelin sheath or the axon around the
oligodendrocytes (Fig. 4A).

View larger version (134K):
[in this window]
[in a new window]
|
Figure 4.
ABC2 in oligodendrocytes by immunoelectron
microscopy. The ultrathin section was cut from the medulla of the
cerebellum. The peroxidase-DAB reaction product from ABC2
immunohistochemistry was intensified with the silver-gold particles.
A, Most of the intense labeling was observed around
lysosomes (arrows), but only particular labeling or none
at all was observed in other organelles at a magnification of 7000×.
Note that there is no specific labeling in the myelin sheath or the
axon around the cell body. AX, Axon; N,
nucleus; V, blood vessel. B,
High-magnification (10,000×) graphs for organellar localization of the
ABC2 in oligodendrocytes. The silver-gold particles representing ABC2
immunoreactivities localized densely in lysosome membranes and
particularly in the trans face of the Golgi
apparatus (arrow). ER,
Endoplasmic reticulum; G, Golgi body;
L, lysosome; M, mitochondria. Scale bar,
500 nm.
|
|
Comparison of the histochemical distribution of ABC2 mRNA
and protein
The x-ray film autoradiograms obtained from brain sections using
an isotope-labeled riboprobe for ABC2 mRNA has been described in our
previous work (Zhao et al., 2000 ). Both dark- and bright-field micrographs were made, and results are partly shown in Figure 5. Brain regions showing intense labeling
for ABC2 mRNA coincided well with those demonstrating ABC2
immunoreactivity (described in this paper); however, a detailed
description has been omitted here.

View larger version (67K):
[in this window]
[in a new window]
|
Figure 5.
Dark- and bright-field micrographs of the
distribution of ABC2 mRNA in brain tissues. Sections, after
hybridization with [35S]-labeled riboprobe for
ABC2, were dipped in a nuclear track emulsion and exposed for 1 week.
Intense labeling was observed in the white matter and weak labeling in
the gray matter throughout the whole brain. The areas around the corpus
callosum (A, coronal section), anterior commissure
(B, sagittal), optic chiasm (C,
sagittal), olfactory bulb (D, sagittal), pontine nuclei
(E, sagittal), and the lobe of cerebellum
(F, sagittal) showed up in the dark-field. The
bright-field micrographs (G-I)
are magnified from the relative regions (E, F),
and the dense silver particles representing ABC2 mRNA are observed over
many cell bodies within the white matter (arrows).
ac, Anterior commissure; CA3, the CA3
field of hippocampus; cc, corpus callosum;
cg, cingulum; fi, fimbria hippocampus;
GL, granular layer of cerebellum; lfp,
longitudinal fasciculus pons; lo, lateral olfactory
tract; M, medulla of cerebellum; MoCb,
molecular layer of cerebellum; ox, optic chiasm;
Pn, pontine nuclei; tfp, transverse
fibers pons. Scale bars, 50 µm.
|
|
Colocalization of ABC2 and LAMP1 or LAMP2 in the neuro-2a
cell line
It has been reported that mouse ABC2 mRNA was detected in the
neuro-2a (N2a), a mouse neuroblastoma cell line, by Northern blot
(Luciani et al., 1994 ). We used this cell line to confirm the lysosomal
localization of ABC2 by double immunostaining with LAMP1 and LAMP2. As
shown in Figure 6, most
ABC2-immunolabeled orgenelles (Fig. 6A,
green, D, red) were found to
colocalize with lysosomal markers, either LAMP1 (Fig.
6B, red) or LAMP2 (Fig. 6E, green), and they were overlapped with
each other by use of the confocal microscope (Fig.
6C,F, yellow).

View larger version (13K):
[in this window]
[in a new window]
|
Figure 6.
Colocalization of ABC2 and lysosomal markers LAMP1
or LAMP2 with confocal microscopy in neuro-2a cells, an ABC2-expressing
mouse neuroblastoma cell line. The green labeling for
ABC2-immunoreactivity (A) and the
red labeling for LAMP1 immunoreactivity
(B) are mostly overlapped as
yellow in the lysosomes (C). In
contrast, the red labeling for ABC2 immunoreactivity
(D) and the green labeling for
LAMP2 immunoreactivity (E) are also overlapped
well as yellow in lysosomes of the neuro-2a cells
(F). Scale bars, 20 µm.
|
|
 |
DISCUSSION |
This study has demonstrated that ABC2 is a novel
lysosome-associated membrane protein and is localized specifically in
oligodendrocytes in the rat brain. A number of ABC transporter proteins
are specific to a particular tissue or organelle and function
specifically by coupling the hydrolysis of ATP to the transmembrane
flux of molecules such as ions, sugars or polysaccharides, steroids,
phospholipids, amino acids or peptides, and proteins, as well as
of chemotherapeutic drugs. However, to date, only a couple of
these transporters have been detected and investigated at length in the
CNS. For example, sulfonylurea receptors, the regulator subunits of
ATP-sensitive potassium channels (Inagaki et al., 1995 , 1996 ), have
been shown to be widely expressed in the rodent brain (Karschin et al.,
1997 ). The present study has provided the first identification of a
mammalian ABC membrane protein that is localized in oligodendrocytes in the mammalian brain and associated with lysosomes. Our findings should
lead to the discovery of currently unknown aspects of both lysosomal
membrane transport processes in oligodendrocytes and the physiological
functions performed by ABC2 in the mammalian CNS.
Specificity of the primary antibody for ABC2
A polyclonal antibody was generated in a rabbit against the
C-terminal domain of rat ABC2, which showed low homology with other
peptides from the sequence databases on line. The antibody was
affinity-purified to investigate the distribution of ABC2 protein in
the rat brain. The specificity of the antibody was assessed by Western
blot analysis. The present study revealed two bands of 260 and 250 kDa
from the COS-1 cells transfected with rat ABC2 expression vector
(pCMVrABC2), whereas no any band was revealed from those transfected
with pCMV vector alone. This is consistent with our previous report
that both 260 and 250 kDa proteins also were detected by anti-HA
antibody in COS-1 cells transfected with an expression vector carrying
ABC2-HA, in which a hemagglutinin epitope (YPYDVPDYA) was introduced
into the C terminus of the ABC2 protein (Zhao et al., 2000 ).
Furthermore, the present study revealed a single band from rat brain
between 260 and 250 kDa. The small difference of the mobilities between ABC2 protein expressed in COS-1 cells and in the brain might be attributable to the difference of glycosylation, because ABC2 is a
glycoprotein (Zhao et al., 2000 ).
Colocalization of ABC2 and CNP in the brain
We have demonstrated that all ABC2-immunolabeled cell bodies in
this study were also colocalized with CNP immunoreactivity. CNP is the
main component of the Wolfgram protein fraction (Drummond and Dean,
1980 ; Sprinkle et al., 1980 ) and has been widely used as a marker for
myelin oligodendrocytes in the CNS. CNP is present in the
cytoplasm-containing compartments of the oligodendrocytes and myelin
sheaths but not in lamellae or cellular membranes (Braun et al., 1988 ).
In contrast, we found that ABC2 immunoreactivity occurred only in cell
bodies and was specifically localized to oligodendrocyte organelles. We
observed that the ABC2-immunostained cells were mainly distributed
within the white matter of the brain, in the interfascicular
oligodendroglia that produce multilamellar myelin sheaths around nerve
axons. In addition, many immunostained oligodendrocytes were observed
in the gray matter, within neurons as so-called satellite cells, or
adjacent to blood vessels. However, the functions of these latter cells
remain unclear. The distribution pattern of immunostained
oligodendrocytes coincided well with those of CNP immunohistochemistry
(Braun et al., 1988 ).
ABC2 as a specific marker for oligodendrocytes but not for
myelin sheaths
Numerous tissue-specific chemical components have been isolated
and identified from myelin oligodendrocytes (as well as from Schwann
cells) and may have been used as specific markers for cell
identification. To date, >40 enzymes, including CNP, ceramide galactosyltransferase, glutathione S-transferase, and
carbonic anhydrase, are actively expressed at specific stages during
myelinization (Newman et al., 1995 ; Wiesinger, 1995 ). However, CNP is
widely used as the marker in experiments involving the adult CNS, as was the case in this study. Other proteins found in the myelin sheath
are galactocerebroside, a kind of typical myelin lipid also used as a
specific marker in cultured cells (Benjamins et al., 1987 ), sulfatide,
cholesterol, ethanolamine phosphatide, lecithin, and plasmalogen
(Morell et al., 1994 ). Furthermore, 60-80% of the protein mass
in the myelin sheath is made up of proteolipid protein and MBP. Other
glycoproteins, such as myelin-associated glycoprotein,
myelin-oligodendrocyte glycoprotein (MOG), and
oligodendrocyte-myelin glycoprotein, have also been isolated
(Newman et al., 1995 ). Although these components exist both in the
myelin-sheath and in oligodendrocytes, a number of them, such as CNP,
MBP, and MOG, are localized in different regions at the ultrastructural
level (Brunner et al., 1989 ). In the present study, we compared not
only the immunocolocalizaiton of ABC2 with CNP but also its
colocalization with MBP, and obtained a similar result. We
therefore propose that, although further investigation is needed into
the expression of ABC2 in the peripheral nervous system and during
development, ABC2 can be used as a specific marker for
oligodendrocytes. We also have compared ABC2 with markers for other
glial cells such as CD11b, in the case of microglial cells, and GFAP,
in the case of astrocytes (Debus et al., 1983 ), and they shown no
cross-immunostaining with each other.
ABC2 as a lysosomal membrane protein
The colocalization of ABC2 with lysosome-associated membrane
proteins (LAMP1 and LAMP2) and the immunoelectron microscopy as
well as crude membrane-immunoblotting results in the present study have
clearly shown ABC2 to be a novel lysosome-associated membrane protein.
Lysosomes are membrane-bound organelles with an acidic internal
milieu containing hydrolytic enzymes for degrading for various
substances. The major structural components of lysosomal membrane are
glycoproteins with molecular weights between 90 and 110 kDa (Peters and
von Figura, 1994 ).
The lysosomal membrane regulates the transport activities of substances
such as proteins, lipids, nucleic acids, and saccharides of the
cellular components as well as toxins, drugs, and heavy metals from the
cytoplasm into the lysosome, as well as the release of digested
molecules from the lysosomal lumen into the cytoplasm. These processes
usually consume energy. Therefore, ABC transporter proteins were
potential candidates to be performing some of these transporter
activities. In this study, we have identified ABC2 as being
specifically localized in the lysosome membranes of oligodendrocytes. Although the ABC protein HMT1, involved in heavy-metal tolerance (Ortiz
et al., 1992 ), and the yeast cadmium factor protein, a glutathione
S-conjugate pump (Li et al., 1996 ), have been found in the
yeast vacuolar membrane (equivalent to the lysosomal compartment), until this study no ABC transporter had as yet been identified as a
mammalian lysosomal membrane protein. It should be noted that almost at
the same time as the completion of this manuscript, one paper did
describe a half-molecule ABC transporter, ABCB9, which was
mainly expressed in rodent testes and was localized in the lysosomes in
transfected cells (Zhang et al., 2000 ). Although data are needed that
directly demonstrate the intracellular localization of ABCB9 (this
half-transporter belongs to a different subfamily than the full-length
ABC2 transporter) in testis, this in vitro data supports our
present in vivo findings. Further studies should be
performed to investigate whether ABC2 also plays the lysosome-specific role in the testis (we have detected ABC2 in testis but further studies
are needed), whether ABCB9 plays a role in both testis and brain, or
whether either protein plays a role in other tissues. Several other
organelle-specific ABC proteins, however, have been reported: four
murine peroxisomal ABC half-transporters (Berger et al., 1999 ), the ALD
protein (ALDP) (Mosser et al., 1993 ), ADL-related protein (ALDRP)
(Holzinger et al., 1997a ), 70 kDa peroxisomal membrane protein
(PMP70), and PMP70-related protein (P70R or PMP69) (Holzinger et al.,
1997b ); the mitochondrial ABC protein (M-ABC1) (Hogue et al.,
1999 ) and ABC7 (Csere et al., 1998 ); and the Tap1 and Tap2 as a
heterodimer associated with ABC transporters in the endoplasmic
reticulum (Gileadi and Higgins, 1997 ).
Significance of ABC2 expressed in the brain
In the ABC1 subfamily, ABC1 and ABCR have been proposed to be
flippases for intracellular cholesterol and protonated
N-retinylidene-phosphatydylethanolamine, respectively (Weng
et al., 1999 ). The N-terminal 40-amino acid sequences including the
first hydrophobic segment, the membrane-spanning domains, and the
nucleotide-binding domains of the four identified members of this
subfamily (ABC1, ABC2, ABC3, and ABCR) between murine and human are
strongly conserved (Zhao et al., 2000 ); however, the fundamental
function of ABC2 remains unknown. The ABC2 gene is located at
chromosome 9q34 (Luciani et al., 1994 ), which is a homogeneous staining
region for an estramustine-resistant human ovarian carcinoma cell line.
One research group has in fact used this cell line to show that
amplification and overexpression of ABC2 contributes to estramustine
resistance (Laing et al., 1998 ). The current findings that ABC2 is
expressed in oligodendrocytes and associated with lysosomes provides
evidence that this transporter should be studied further in the CNS.
Investigation of cultured oligodendrocytes may potentially reveal an
essential cellular role for ABC transporters. Oligodendrocytes are well
known as the myelinating glial cells, and hypomyelination or
demyelination diseases such as genetic leukodystrophy, multiple
sclerosis, and multisystem atrophy are all closely linked to the
intracellular metabolism connected with oligodendrocyte lysosomes. This
strongly suggests that ABC2, as a lysosomal membrane transporter of
oligodendrocytes, may be involved in normal myelination and therefore
may be associated in some way with these degeneration processes. As
with the other members of ABC1 subfamily, ABC1 and ABCR have been
identified as the causal genes for certain genetic diseases. Further
investigation of ABC2 will provide more insight into its functional significance.
 |
FOOTNOTES |
Received June 26, 2000; revised Oct. 31, 2000; accepted Nov. 10, 2000.
This research was supported in part by grants from the Ministry of
Education, Science, Sports, and Culture of Japan (S.S., S.K., and N.I.)
and Core Research for Evolutional Science and Technology of Japan
Science and Technology Corporation (N.I. and S.S.), as well as
by a grant to C.J.Z. from the Foundation for Growth Science (Tokyo,
Japan). We thank Dr. Masanori Nakata (Jichi Medical School, Department
of Physiology, Tochigi, Japan) for providing the neuro-2a cell
line, and Sachiko H. Kajimoto and Mio Watanabe (Showa University School
of Pharmaceutical Sciences) for their assistance with this study.
Correspondence should be addressed to Dr. Seiji Shioda, Department of
Anatomy, Showa University School of Medicine, Tokyo 142-8555, Japan. E-mail: shioda{at}med.showa-u.ac.jp.
 |
REFERENCES |
-
Allikmets R,
Gerrard B,
Hutchinson A,
Dean M
(1996)
Characterization of the human ABC superfamily: isolation and mapping of 21 new genes using the expressed sequence tags database.
Hum Mol Genet
5:1649-1655[Abstract/Free Full Text].
-
Allikmets R,
Singh N,
Sun H,
Shroyer NF,
Hutchinson A,
Chidambaram A,
Gerrard B,
Baird L,
Stauffer D,
Peiffer A,
Rattner A,
Smallwood P,
Li Y,
Anderson KL,
Lewis RA,
Nathans J,
Leppert M,
Dean M,
Lupski JR
(1997)
A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy.
Nat Genet
15:236-246[Web of Science][Medline].
-
Benjamins JA,
Callahan RE,
Montgomery IN,
Studzinski DM,
Dyer CA
(1987)
Production and characterization of high titer antibodies to galactocerebroside.
J Neuroimmunol
14:325-338[Web of Science][Medline].
-
Berger J,
Albet S,
Bentejac M,
Netik A,
Holzinger A,
Roscher AA,
Bugaut M,
Forss-Petter S
(1999)
The four murine peroxisomal ABC-transporter genes differ in constitutive, inducible and developmental expression.
Eur J Biochem
265:719-727[Web of Science][Medline].
-
Bodzioch M,
Orso E,
Klucken J,
Langmann T,
Bottcher A,
Diederich W,
Drobnik W,
Barlage S,
Buchler C,
Porsch-Ozcurumez M,
Kaminski WE,
Hahmann HW,
Oette K,
Rothe G,
Aslanidis C,
Lackner KJ,
Schmitz G
(1999)
The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease.
Nat Genet
22:347-351[Web of Science][Medline].
-
Braun PE,
Sandillon F,
Edwards A,
Matthieu JM,
Privat A
(1988)
Immunocytochemical localization by electron microscopy of 2',3'-cyclic nucleotide 3'-phosphodiesterase in developing oligodendrocytes of normal and mutant brain.
J Neurosci
8:3057-3066[Abstract].
-
Brooks-Wilson A,
Marcil M,
Clee SM,
Zhang LH,
Roomp K,
van Dam M,
Yu L,
Brewer C,
Collins JA,
Molhuizen HO,
Loubser O,
Ouelette BF,
Fichter K,
Ashbourne-Excoffon KJ,
Sensen CW,
Scherer S,
Mott S,
Denis M,
Martindale D,
Fronhlich J,
Morgan K,
Koop B,
Pimstone S,
Kastelein JJ,
Genest Jr J,
Hayden MR
(1999)
Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency.
Nat Genet
22:336-345[Web of Science][Medline].
-
Brunner C,
Lassmann H,
Waehneldt TV,
Matthieu JM,
Linington C
(1989)
Differential ultrastructural localization of myelin basic protein, myelin/oligodendroglial glycoprotein, and 2',3'-cyclic nucleotide 3'-phosphodiesterase in the CNS of adult rats.
J Neurochem
52:296-304[Web of Science][Medline].
-
Csere P,
Lill R,
Kispal G
(1998)
Identification of a human mitochondrial ABC transporter, the functional orthologue of yeast Atm1p.
FEBS Lett
441:266-270[Web of Science][Medline].
-
Dean M,
Allikmets R
(1995)
Evolution of ATP-binding cassette transporter genes.
Curr Opin Genet Dev
5:779-785[Web of Science][Medline].
-
Debus E,
Weber K,
Osborn M
(1983)
Monoclonal antibodies specific for glial fibrillary acidic (GFA) protein and for each of the neurofilament triplet polypeptides.
Differentiation
25:193-203[Web of Science][Medline].
-
Decottignies A,
Goffeau A
(1997)
Complete inventory of yeast ABC proteins.
Nat Genet
15:137-145[Web of Science][Medline].
-
Doige CA,
Ames GFL
(1993)
ATP-dependent transport systems in bacteria and humans: relevance to cystic fibrosis and multidrug resistance.
Annu Rev Microbiol
47:291-319[Medline].
-
Drummond RJ,
Dean G
(1980)
Comparison of 2',3'-cyclic nucleotide 3'-phosphodiesterase and the major component of Wolfgram protein W1.
J Neurochem
35:1155-1165[Medline].
-
Dubois-Dalcq M,
Feigenbaum V,
Aubourg P
(1999)
The neurobiology of X-linked adrenoleukodystrophy, a demyelinating peroxisomal disorder.
Trends Neurosci
22:4-12[Web of Science][Medline].
-
Gallyas F,
Gorcs T,
Merchenthaler I
(1982)
High-grade intensification of the end-product of the diaminobenzidine reaction for peroxidase histochemistry.
J Histochem Cytochem
30:183-184[Abstract].
-
Gileadi U,
Higgins CF
(1997)
Membrane topology of the ATP-binding cassette transporter associated with antigen presentation (Tap1) expressed in Escherichia coli.
J Biol Chem
272:11103-11108[Abstract/Free Full Text].
-
Guan JL,
Wang QP,
Shioda S
(2000)
Observation of the ultrastructure and synaptic relationaships of angiotensin II-like immunoreactive neurons in the rat area postrema.
Synapse
38:231-237[Web of Science][Medline].
-
Higgins CF
(1992)
ABC transporters: from microorganisms to man.
Annu Rev Cell Biol
8:67-113[Web of Science].
-
Higgins CF
(1994)
Flip-flop: the transmembrane translocation of lipids.
Cell
79:393-395[Web of Science][Medline].
-
Hogue DL,
Liu L,
Ling V
(1999)
Identification and characterization of a mammalian mitochondrial ATP-binding cassette membrane protein.
J Mol Biol
285:379-389[Web of Science][Medline].
-
Holzinger A,
Kammerer S,
Berger J,
Roscher AA
(1997a)
cDNA cloning and mRNA expression of the human adrenoleukodystrophy related protein (ALDRP), a peroxisomal ABC transporter.
Biochem Biophys Res Commun
239:261-264[Web of Science][Medline].
-
Holzinger A,
Kammerer S,
Roscher AA
(1997b)
Primary structure of human PMP69, a putative peroxisomal ABC-transporter.
Biochem Biophys Res Commun
237:152-157[Web of Science][Medline].
-
Hyde SC,
Emsley P,
Hartshorn MJ,
Mimmack MM,
Gileadi U,
Pearce SR,
Gallagher MP,
Gill DR,
Hubbard RE,
Higgins CF
(1990)
Structural model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance and bacterial transport.
Nature
346:362-365[Medline].
-
Illing M,
Molday LL,
Molday RS
(1997)
The 220-kDa rim protein of retinal rod outer segments is a member of the ABC transporter superfamily.
J Biol Chem
272:10303-10310[Abstract/Free Full Text].
-
Inagaki N,
Gonoi T,
Clement JP,
Wang CZ,
Aguilar-Bryan L,
Bryan J,
Seino S
(1996)
A family of sulfonylurea receptors determines the pharmacological properties of ATP-sensitive K channels.
Neuron
16:1011-1017[Web of Science][Medline].
-
Inagaki N,
Gonoi T,
Clement JP4,
Namba N,
Inazawa J,
Gonzalez G,
Aguilar-Bryan L,
Seino S,
Bryan J
(1995)
Reconstitution of IKATP: an inward rectifier subunit plus the sulfonylurea receptor.
Science
270:1166-1170[Abstract/Free Full Text].
-
Kamijo K,
Taketani S,
Yokota S,
Osumi T,
Hashimoto T
(1990)
The 70-kDa peroxisomal membrane protein is a member of the Mdr (P-glycoprotein)-related ATP-binding protein superfamily.
J Biol Chem
265:4534-4540[Abstract/Free Full Text].
-
Karlsson K,
Carlsson SR
(1998)
Sorting of lysosomal membrane glycoproteins lamp-1 and lamp-2 into vesicles distinct from mannose 6-phosphate receptor/gamma-adaptin vesicles at the trans-Golgi network.
J Biol Chem
273:18966-18973[Abstract/Free Full Text].
-
Karschin C,
Ecke C,
Ashcroft FM,
Karschin A
(1997)
Overlapping distribution of K (ATP) channel-forming Kir6.2 subunit and the sulfonylurea receptor SUR1 in rodent brain.
FEBS Lett
401:59-64[Web of Science][Medline].
-
Klugbauer N,
Hofmann F
(1996)
Primary structure of a novel ABC transporter with a chromosomal localization on the band encoding the multidrug resistance-associated protein.
FEBS Lett
391:61-65[Web of Science][Medline].
-
Laing NM,
Belinsky MG,
Kruh GD,
Bell DW,
Boyd JT,
Barone L,
Testa JR,
Tew KD
(1998)
Amplification of the ATP-binding cassette 2 transporter gene is functionally linked with enhanced efflux of estramustine in ovarian carcinoma cells.
Cancer Res
58:1332-1337[Abstract/Free Full Text].
-
Li ZS,
Szczypka M,
Lu YP,
Thiele DJ,
Rea PA
(1996)
The yeast cadmium factor protein (YCF1) is a vacuolar glutathione S-conjugate pump.
J Biol Chem
271:6507-6517.
-
Linton KJ,
Higgins CF
(1998)
The Escherichia coli ATP-binding cassette (ABC) proteins.
Mol Microbiol
28:5-13[Web of Science][Medline].
-
Luciani MF,
Denizot F,
Savary S,
Mattei MG,
Chimini G
(1994)
Cloning of two novel ABC transporters mapping on human chromosome 9.
Genomics
21:150-159[Web of Science][Medline].
-
Milligan CE,
Conningham TJ,
Levitt P
(1991)
Differential immunochemical markers reveal the normal distribution of brain macrophages and microglia in the developing rat brain.
J Comp Neurol
314:125-135[Web of Science][Medline].
-
Morell P,
Quarles RH,
Norton WT
(1994)
Myelin formation, structure and biochemistry.
In: Basic neurochemistry (Siegel W,
Agronoff B,
Albers RW,
Molinoff P,
eds), pp 117-143. New York: Raven.
-
Mosser J,
Douar AM,
Sarde CO,
Kioschis P,
Feil R,
Moser H,
Poustka AM,
Mandel JL,
Aubourg P
(1993)
Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters.
Nature
361:726-730[Medline].
-
Newman S,
Saito M,
Yu RK
(1995)
Biochemistry of myelin protein and enzymes.
In: Neuroglia (Kettenmann H,
Ransom BR,
eds), pp 535-554. New York: Oxford UP.
-
Orso E,
Broccardo C,
Kaminski WE,
Bottcher A,
Liebisch G,
Drobnik W,
Gotz A,
Chambenoit O,
Diederich W,
Langmann T,
Spruss T,
Luciani MF,
Rothe G,
Lackner KJ,
Chimini G,
Schmitz G
(2000)
Transport of lipids from Golgi to plasma membrane is defective in Tangier disease patients and Abc1-deficient mice.
Nat Genet
24:192-196[Web of Science][Medline].
-
Ortiz DF,
Kreppel L,
Speiser DM,
Scheel G,
McDonald G,
Ow DW
(1992)
Heavy metal tolerance in the fission yeast requires an ATP-binding cassette-type vacuolar membrane transporter.
EMBO J
11:3491-3499[Web of Science][Medline].
-
Paulusma CC,
Bosma PJ,
Zaman GJ,
Bakker CT,
Otter M,
Scheffer GL,
Scheper RJ,
Borst P,
Oude Elferink RP
(1996)
Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene.
Science
271:1126-1128[Abstract].
-
Peters A,
Palay SL,
Webster J
(1976)
In: The fine structure of the nervous system: the neurons and supporting cells. Philadelphia: W. B. Saunders.
-
Peters C,
von Figura K
(1994)
Biogenesis of lysosomal membranes.
FEBS Lett
346:108-114[Web of Science][Medline].
-
Ringpfeil F,
Lebwohl MG,
Christiano AM,
Uitto J
(2000)
Pseudoxanthoma elasticum: mutations in the MRP6 gene encoding a transmembrane ATP-binding cassette (ABC) transporter.
Proc Natl Acad Sci USA
97:6001-6006[Abstract/Free Full Text].
-
Rust S,
Rosier M,
Funke H,
Real J,
Amoura Z,
Piette JC,
Deleuze JF,
Brewer HB,
Duverger N,
Denefle P,
Assmann G
(1999)
Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1.
Nat Genet
22:352-355[Web of Science][Medline].
-
Saurin W,
Hofnung M,
Dassa E
(1999)
Getting in or out: early segregation between importers and exporters in the evolution of ATP-binding cassette (ABC) transporters.
J Mol Evol
48:22-41[Web of Science][Medline].
-
Sheppard DN,
Welsh MJ
(1999)
Structure and function of the CFTR chloride channel.
Physiol Rev
79:S23-45.
-
Shioda S,
Shuto Y,
Somogyvari-Vigh A,
Legradi G,
Onda H,
Coy DH,
Nakajo S,
Arimura A
(1997)
Localization and gene expression of the receptor for pituitary adenylate cyclase-activating polypeptide in the rat brain.
Neurosci Res
28:345-354[Web of Science][Medline].
-
Sprinkle TJ,
Agee JF,
Tippins RB,
Chamberlain CR,
Faguet GB,
De Vries GH
(1987)
Monoclonal antibody production to human and bovine 2',3'-cyclic nucleotide 3'-phosphodiestrase (CNPase): high-specificity recognition in whole brain acetone powders and conservation of sequence between CNP1 and CNP2.
Brain Res
426:349-357[Web of Science][Medline].
-
Sprinkle TJ,
Wells MR,
Garver FA,
Smith DB
(1980)
Studies on the Wolfgram high molecular weight CNS myelin proteins: relationship to 2',3'-cyclic nucleotide 3'-phosphodiesterase.
J Neurochem
35:1200-1208[Medline].
-
Strautnieks SS,
Bull LN,
Knisely AS,
Kocoshis SA,
Dahl N,
Arnell H,
Sokal E,
Dahan K,
Childs S,
Ling V,
Tanner MS,
Kagalwalla AF,
Nemeth A,
Pawlowska J,
Baker A,
Mieli-Vergani G,
Freimer NB,
Gardiner RM,
Thompson RJ
(1998)
A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis.
Nat Genet
20:233-238[Web of Science][Medline].
-
Thomas PM,
Cote GJ,
Wohllk N,
Haddad B,
Mathew PM,
Rabl W,
Aguilar-Bryan L,
Gagel RF,
Bryan J
(1995)
Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy.
Science
268:426-429[Abstract/Free Full Text].
-
Weng J,
Mata NL,
Azarian SM,
Tzekov RT,
Birch DG,
Travis GH
(1999)
Insights into the function of Rim protein in photoreceptors and etiology of Stargardt's disease from the phenotype in abcr knockout mice.
Cell
98:13-23[Web of Science][Medline].
-
Wiesinger H
(1995)
Glia-specific enzyme systems.
In: Neuroglia (Kettenmann H,
Ransom BR,
eds), pp 488-499. New York: Oxford UP.
-
Zhang F,
Zhang W,
Lin L,
Fisher CL,
Hui D,
Childs S,
Dorovini-Zis K,
Ling V
(2000)
Characterization of ABCB9, an ATP-binding cassette protein associated with lysosomes.
J Biol Chem
275:23287-23294[Abstract/Free Full Text].
-
Zhao LX,
Zhou CJ,
Tanaka A,
Nakata M,
Hirabayashi T,
Amachi T,
Shioda S,
Ueda K,
Inagaki N
(2000)
Cloning, characterization and tissue distribution of the rat ATP-binding cassette (ABC) transporter ABC2/ABCA2.
Biochem J
350:865-872.
-
Zhou CJ,
Shioda S,
Shibanuma M,
Nakajo S,
Funahashi H,
Nakai Y,
Arimura A,
Kikuyama S
(1999)
Pituitary adenylate cyclase-activating polypeptide receptors during development: expression in the rat embryo at primitive streak stage.
Neuroscience
93:375-391[Medline].
Copyright © 2001 Society for Neuroscience 0270-6474/01/213849-09$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
E. Currie, B. King, A. L. Lawrenson, L. K. Schroeder, A. M. Kershner, and G. J. Hermann
Role of the Caenorhabditis elegans Multidrug Resistance Gene, mrp-4, in Gut Granule Differentiation
Genetics,
November 1, 2007;
177(3):
1569 - 1582.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Bhattacharya, A. Das, K. Mallya, and I. Ahmad
Maintenance of retinal stem cells by Abcg2 is regulated by notch signaling
J. Cell Sci.,
August 1, 2007;
120(15):
2652 - 2662.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Sakai, Y. Tanaka, M. Tanaka, N. Ban, K. Yamada, Y. Matsumura, D. Watanabe, M. Sasaki, T. Kita, and N. Inagaki
ABCA2 Deficiency Results in Abnormal Sphingolipid Metabolism in Mouse Brain
J. Biol. Chem.,
July 6, 2007;
282(27):
19692 - 19699.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. K. Schroeder, S. Kremer, M. J. Kramer, E. Currie, E. Kwan, J. L. Watts, A. L. Lawrenson, and G. J. Hermann
Function of the Caenorhabditis elegans ABC Transporter PGP-2 in the Biogenesis of a Lysosome-related Fat Storage Organelle
Mol. Biol. Cell,
March 1, 2007;
18(3):
995 - 1008.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. T. Mack, V. Beljanski, A. M. Soulika, D. M. Townsend, C. B. Brown, W. Davis, and K. D. Tew
"Skittish" Abca2 Knockout Mice Display Tremor, Hyperactivity, and Abnormal Myelin Ultrastructure in the Central Nervous System
Mol. Cell. Biol.,
January 1, 2007;
27(1):
44 - 53.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Schaheen, G. Patton, and H. Fares
Suppression of the cup-5 mucolipidosis type IV-related lysosomal dysfunction by the inactivation of an ABC transporter in C. elegans
Development,
October 1, 2006;
133(19):
3939 - 3948.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Kubo, S. Sekiya, M. Ohigashi, C. Takenaka, K. Tamura, S. Nada, T. Nishi, A. Yamamoto, and A. Yamaguchi
ABCA5 Resides in Lysosomes, and ABCA5 Knockout Mice Develop Lysosomal Disease-Like Symptoms
Mol. Cell. Biol.,
May 15, 2005;
25(10):
4138 - 4149.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Bjorkhem and S. Meaney
Brain Cholesterol: Long Secret Life Behind a Barrier
Arterioscler Thromb Vasc Biol,
May 1, 2004;
24(5):
806 - 815.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
T. Langmann, R. Mauerer, A. Zahn, C. Moehle, M. Probst, W. Stremmel, and G. Schmitz
Real-Time Reverse Transcription-PCR Expression Profiling of the Complete Human ATP-Binding Cassette Transporter Superfamily in Various Tissues
Clin. Chem.,
February 1, 2003;
49(2):
230 - 238.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Santamarina-Fojo, A. T. Remaley, E. B. Neufeld, and H. B. Brewer Jr.
Regulation and intracellular trafficking of the ABCA1 transporter
J. Lipid Res.,
September 1, 2001;
42(9):
1339 - 1345.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Dean, Y. Hamon, and G. Chimini
The human ATP-binding cassette (ABC) transporter superfamily
J. Lipid Res.,
July 1, 2001;
42(7):
1007 - 1017.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. B. Neufeld, A. T. Remaley, S. J. Demosky, J. A. Stonik, A. M. Cooney, M. Comly, N. K. Dwyer, M. Zhang, J. Blanchette-Mackie, S. Santamarina-Fojo, et al.
Cellular Localization and Trafficking of the Human ABCA1 Transporter
J. Biol. Chem.,
July 13, 2001;
276(29):
27584 - 27590.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|